ALC logo

Alcon (ALC)

Profile

Full Name

Alcon Inc.

Ticker Symbol

ALC

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Switzerland

IPO

April 9, 2019

Indexes

Not included

Website

http://www.alcon.com

Employees

25599

Key Details

Price

$92.41(+0.39%)

Market cap

Last Dividend

$0.26

TTM Dividend yield

0.29%

Annual revenue

$9.91B(+4.82% YoY)

Annual EPS

$2.05(+4.59% YoY)

PE ratio

45.08

Next earnings date

May 14, 2025

Next ex-dividend date

May 14, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$92.41
ALC price is $92.41

30-Day Relative Volume

0.54
ALC 30-day relative volume is 0.54

Price Performance

Price Today change

+0.39%
ALC price is up +0.39% today

Price YTD change

+8.86%
ALC price is up +8.86% since January 1st

Price 1-year change

+16.97%
ALC price is up +16.97% year-on-year

Price 3-year change

+20.17%
ALC price is up +20.17% over the past 3 years

Price Range

Price All-time high

$101.10
ALC price is currently -8.60% below its historical high of $101.10

Price 3-year low

$55.21
ALC price is currently +67.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.71B
ALC market capitalization is $45.71 billion

Market cap 3-year change

+21.28%
ALC market capitalization is up +21.28% over the past 3 years

Market cap All-time high

$51.07B
ALC market capitalization is currently -10.50% below its historical high of $51.07 billion

Market cap sector rank

97.37%
ALC market capitalization is higher than 97.37% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.28%
ALC shares outstanding is up +0.28% year-on-year

Shares Outstanding 3-Year Change

+0.92%
ALC shares outstanding is up +0.92% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
ALC beta is 0.70

200-day SMA

$91.19
ALC price is currently +1.34% above its 200-day simple moving average

50-day SMA

$90.65
ALC price is currently +1.95% above its 50-day simple moving average

RSI

54.04
ALC 14-day relative strength index is 54.04

Volume

0.54
ALC 30-day relative volume is 0.54

ATR

$2.60
ALC average true range is $2.60

10-day Historical Volatility

64.65%
ALC 10-day historical volatility is 64.65%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.26
ALC last dividend was $0.26 per share, with an ex-dividend date of May 14, 2024

Next Dividend

$0.34
ALC has announced a dividend of $0.34 per share, with an ex-dividend date set for May 14, 2025

Dividend per share

Dividend per share

$0.26
ALC annual dividend per share is $0.26

Dividend per share Sector Rank

13.95%
ALC annual dividend per share is higher than 13.95% of companies in Healthcare sector

Dividend per share 1-Year Change

+12.04%
ALC annual dividend per share is up +12.04% year-on-year

Dividend per share 3-Year Change

+140.93%
ALC annual dividend per share is up +140.93% over the past 3 years

Dividend yield

Dividend yield

0.29%
ALC annual dividend yield is 0.29%

Dividend yield Sector Rank

3.53%
ALC annual dividend yield is higher than 3.53% of companies in Healthcare sector

Other

Payout ratio

12.77%
ALC annual payout ratio is 12.77%

Dividends paid

$130.00M
ALC annual dividends paid is $130.00 million

Free cash flow

$1.41B
ALC annual free cash flow is $1.41 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.91B
ALC annual revenue is $9.91 billion

Revenue Analysts estimate

$10.42B
ALC annual revenue is currently -4.85% lower than the consensus analysts' forecast

Revenue 1-year change

+4.82%
ALC annual revenue is up +4.82% year-on-year

Revenue Sector rank

94.29%
ALC annual revenue is higher than 94.29% of companies in Healthcare sector

EPS

EPS

$2.05
ALC annual earnings per share is $2.05

EPS Analysts estimate

$3.24
ALC annual earnings per share is currently -36.64% lower than the consensus analysts' forecast

EPS 1-year change

+4.59%
ALC annual earnings per share is up +4.59% year-on-year

EPS Sector rank

92.4%
ALC annual earnings per share is higher than 92.4% of companies in Healthcare sector

Profit

Gross profit

$5.51B
ALC annual gross profit is $5.51 billion

Gross margin

55.62%
ALC annual gross profit margin is 55.62%

Operating profit

$1.41B
ALC annual operating income is $1.41 billion

Operating margin

14.26%
ALC annual operating profit margin is 14.26%

Net income

$1.02B
ALC annual net profit is $1.02 billion

Net margin

10.27%
ALC annual net profit margin is 10.27%

Expenses

Total expenses

$8.50B
ALC annual total expenses is $8.50 billion

Operating expenses

$4.10B
ALC annual total operating expenses is $4.10 billion

Cost of goods sold

$4.40B
ALC annual cost of goods sold is $4.40 billion

Selling, general & administrative expenses

$3.25B
ALC annual SGA is $3.25 billion

Depreciation and amortization

$1.23B
ALC annual depreciation & amortization is $1.23 billion

Interest expense

$192.00M
ALC annual interest expense is $192.00 million

Income tax

$238.00M
ALC annual income tax is $238.00 million

EBIT & EBITDA

EBIT

$1.45B
ALC annual earnings before interest & taxes is $1.45 billion

EBITDA

$2.68B
ALC annual EBITDA is $2.68 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$30.35B
ALC annual total assets is $30.35 billion

Non current assets

$24.04B
ALC annual long term assets is $24.04 billion

Current assets

$6.31B
ALC annual total current assets is $6.31 billion

Cash and cash equivalents

$1.83B
ALC annual cash & cash equivalents is $1.83 billion

Accounts receivable

$1.85B
ALC annual accounts receivable is $1.85 billion

Inventory

$2.27B
ALC annual inventory is $2.27 billion

Liabilities

Total liabilities

$8.79B
ALC annual total liabilities is $8.79 billion

Long term liabilities

$6.52B
ALC annual total long term liabilities is $6.52 billion

Current liabilities

$2.28B
ALC annual total current liabilities is $2.28 billion

Accounts payable

$773.00M
ALC annual accounts payable is $773.00 million

Debt

Total debt

$5.14B
ALC annual total debt is $5.14 billion

Total debt 1-year change

+0.02%
ALC annual total debt is up +0.02% year-on-year

Long term debt

$4.97B
ALC annual long term debt is $4.97 billion

Short term debt

$169.00M
ALC annual short term debt is $169.00 million

Equity & Capital

Shareholders equity

$21.55B
ALC annual stockholders equity is $21.55 billion

Book value

$21.55B
ALC annual book value is $21.55 billion

Retained earnings

-
ALC annual retained earnings value is unknown

Working capital

$4.03B
ALC annual working capital is $4.03 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.08B
ALC annual cash flow from operations is $2.08 billion

Cash from operations 1-year change

+49.64%
ALC annual cash flow from operations is up +49.64% year-on-year

Cash from investing

-$1.17B
ALC annual cash flow from investing activities is -$1.17 billion

Cash from investing 1-year change

-6.67%
ALC annual cash flow from investing activities is down -6.67% year-on-year

Cash from financing

-$322.00M
ALC annual cash flow from financing activities is -$322.00 million

Cash from financing 1-year change

-52.61%
ALC annual cash flow from financing activities is down -52.61% year-on-year

CAPEX

CAPEX

$670.00M
ALC annual capital expenditures is $670.00 million

CAPEX 1-year change

-21.27%
ALC annual capital expenditures is down -21.27% year-on-year

Free Cash Flow

Free cash flow

$1.41B
ALC annual free cash flow is $1.41 billion

Free cash flow 1-year change

+162.01%
ALC annual free cash flow is up +162.01% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.62%
ALC annual gross profit margin is 55.62%

Operating margin

14.26%
ALC annual operating profit margin is 14.26%

Net margin

10.27%
ALC annual net profit margin is 10.27%

ROA & ROE

ROA

3.40%
ALC annual return on assets is 3.40%

ROE

4.83%
ALC annual return on equity is 4.83%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

45.08
ALC price to earnings ratio is 45.08

PE ratio Sector rank

75.98%
ALC price to earnings ratio is higher than 75.98% of companies in Healthcare sector

PB Ratio

PB ratio

2.12
ALC price to book ratio is 2.12

PB ratio Sector rank

64.25%
ALC price to book ratio is higher than 64.25% of companies in Healthcare sector

PS Ratio

PS ratio

4.61
ALC price to sales ratio is 4.61

PS ratio Sector rank

65%
ALC price to sales ratio is higher than 65% of companies in Healthcare sector

Enterprise value

Enterprise value

$49.01B
ALC enterprise value is $49.01 billion

Enterprise value Sector rank

97.52%
ALC enterprise value is higher than 97.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

23.85
ALC EV/EBITDA is 23.85

EV/EBITDA Sector rank

93.13%
ALC EV/EBITDA is higher than 93.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.77
ALC annual current ratio is 2.77

Quick ratio

1.77
ALC annual quick ratio is 1.77

Leverage

Debt to equity

0.22
ALC annual debt to equity ratio is 0.22

Interest coverage ratio

7.54
ALC annual interest coverage ratio is 7.54

Risk & Stability

Piotroski F-Score

-
ALC piotroski f-score value is unknown

Altman Z-Score

-
ALC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 31, 25 Keybanc
Overweight
Mar 28, 25 Needham
Buy
Mar 28, 25 Mizuho
Outperform
Mar 20, 25 Needham
Buy
Feb 27, 25 Needham
Buy
Feb 27, 25 Baird
Outperform
Feb 26, 25 Needham
Buy
Jan 24, 25 Needham
Buy
Jan 24, 25 Keybanc
Overweight
Dec 17, 24 Needham
Buy

Institutional Ownership

Similar stocks

HLN logo
Haleon (HLN)
TAK logo
Takeda Pharmaceutical Company Limited (TAK)
EW logo
Edwards Lifesciences (EW)
VEEV logo
Veeva Systems (VEEV)
ARGX logo
argenx SE (ARGX)
HUM logo
Humana (HUM)
BDX logo
Becton Dickinson and Company (BDX)
IDXX logo
IDEXX Laboratories (IDXX)
CAH logo
Cardinal Health (CAH)
  • What is the ticker symbol for Alcon?
  • Does Alcon pay dividends?
  • What sector is Alcon in?
  • What industry is Alcon in?
  • What country is Alcon based in?
  • When did Alcon go public?
  • Is Alcon in the S&P 500?
  • Is Alcon in the NASDAQ 100?
  • Is Alcon in the Dow Jones?
  • When was Alcon's last earnings report?
  • When does Alcon report earnings?
  • Should I buy Alcon stock now?

What is the ticker symbol for Alcon?

The ticker symbol for Alcon is NYSE:ALC

Does Alcon pay dividends?

Yes, Alcon pays dividends. The last payment was $0.26, with an ex-dividend date on May 14, 2024

What sector is Alcon in?

Alcon is in the Healthcare sector

What industry is Alcon in?

Alcon is in the Medical Instruments & Supplies industry

What country is Alcon based in?

Alcon is headquartered in Switzerland

When did Alcon go public?

Alcon's initial public offering (IPO) was on April 9, 2019

Is Alcon in the S&P 500?

No, Alcon is not included in the S&P 500 index

Is Alcon in the NASDAQ 100?

No, Alcon is not included in the NASDAQ 100 index

Is Alcon in the Dow Jones?

No, Alcon is not included in the Dow Jones index

When was Alcon's last earnings report?

Alcon's most recent earnings report was on Feb 26, 2025

When does Alcon report earnings?

The next expected earnings date for Alcon is May 14, 2025

Should I buy Alcon stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page